Tagrisso 80 MG tablet 30S

Ended Awarded Last action

Contract number
SPE2DR26F4E7X
Awardee
Awarding agency
Obligated
$24,876

Award facts

Contract value 100% obligated
$24,876.30 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

On January 12, 2026, the Defense Logistics Agency awarded a delivery order valued at $24,876.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for the supply of Tagrisso 80 mg tablets in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of February 3, 2026, carries no set-aside designation and represents a competitive award to the prime contractor. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), a major pharmaceutical distribution and healthcare solutions provider serving federal government agencies.

This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. Through this prime IDC structure, AmerisourceBergen serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, establishing the company as a critical vendor within the Department of Defense medical supply chain.

Quick answers

Who was awarded contract SPE2DR26F4E7X?

SPE2DR26F4E7X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.

How much is contract SPE2DR26F4E7X worth?

The government has obligated $24,876 on SPE2DR26F4E7X.

Is contract SPE2DR26F4E7X an order under another contract?

Yes. SPE2DR26F4E7X is a delivery order under SPE2DR25D3012, an indefinite delivery contract.

Was contract SPE2DR26F4E7X competed?

The extent of competition for SPE2DR26F4E7X was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award